Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: ChemMedChem. 2012 Mar 13;7(5):861–870. doi: 10.1002/cmdc.201200049

Figure 2.

Figure 2

Crystal structures of complexes between BaDHPS and pyridazine-derived inhibitors. a) Details of the interactions of compound 1 with key residues within the pterin binding site of BaDHPS. [21] b–f) Similar representations for compounds 19 (b), 23 (c), 25 (d)*, 17 (e), and 24 (f). *25 (d) binds in two conformations within the BaDHPS dimer and these are superimposed in the figure.